Biologics Safety Testing Market 2021-2027 Global Industry Analysis

Precision Business Insights published a research report on "Biologics Safety Testing Market: By Product Type (Reagents and Kits, Instruments, Services), By Test Type (Sterility Tests, Bioburden Tests, Endotoxin Tests, Residual Host Contamination detection Tests, Cell Line Authentication and Characterization Tests, Others), By Application (Cellular and Gene Therapy, Vaccine and Therapeutics Development, Tissue and Tissue-Related Products Testing, Blood and Blood-Related Products Testing, Stem Cell Research), By End-User (Pharmaceutical Companies, Biotechnology Companies), and Geography - Global/Region/Country Forecast to 2027".

Biologics safety testing market was valued at USD 2.9 Billion in 2020 and is anticipated to grow at USD 6.21 Billion till 2027 recording a CAGR of 11.5.% during the forecast period 2021-2027.

View detailed Report Description at https://precisionbusinessinsights.com/market-reports/biologics-safety-testing-market/

Technological Advancements in Biologics Safety Testing Methods will Boost Biologics Safety Testing Markets
Biologics are the huge and multifaceted molecules obtained from the genes of living being through advanced DNA technologies. Chronic diseases such as cancer, rheumatoid arthritis are treated using biologics. Monoclonal antibodies and recombinant proteins are the complex molecules. Biologics safety testing is performed for the safety of the patient. Several different tests like bioburden tests, sterility tests, residual host contamination detection tests and endotoxins test are used to perform biological safety testing.

Strict regulatory rules for the approval of the product, growing R&D activities by industries like biotechnology and pharmaceutical for developing new biologics to treat chronic illnesses like cancer and diabetes, growing funding from private and public sectors, increase in biologic product launchings and technological developments of biologics safety testing procedures are anticipated to drive the growth of biologics safety testing market over the forecast time span 2021-2027. But, high price of biologics safety testing can hinder the biologics safety testing market growth. Moreover, strategies followed by key players such as acquisitions, collaborations, launching of novel tests greatly contribute towards driving the biologics safety testing market immensely. For example, Abreos Biosciences made partnership with True Diagnostics in March 2016 for developing the point-of-care tests for biologics.

North America to Hold Dominant Revenue Share in Biologics Safety Testing Market
On the basis of regional basis, global biologics safety testing market is categorized into major regions including North America, Europe, Middle East, Latin America, Asia Pacific and Africa. Among all these regions, North America is dominating the market due to the factors such as well-developed health infrastructure of the region and emerging several industry players in the market. Biologics safety testing market in Europe witnesses a significant share because of business expansion by key players in UK and Germany and huge adoption of novel technologies. For example, European Research Council rewarded $830 Mn to life sciences research in Europe. Favorable regulatory policies and growing awareness among people related to biologics safety testing are the factors enhancing the growth of the biologics safety market in Asia Pacific.

Request sample research report at https://precisionbusinessinsights.com/request-sample?product_id=18768

Competitive Analysis
There are several key players working in Biologics Safety Testing Market, which are Charles River Laboratories (U.S.), Pace Analytical Services Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), WuXi Apptec (China), Sartorius AG (Germany), Toxikon Corporation (U.S.), SGS SA (Switzerland), Merck KGaA (Germany), Sterigenics International, LLC (U.S.), Abreos Biosciences (U.S.) and True Diagnostics, Inc. (U.S.).

Contact:
Mr. Satya
Precision Business InsightsTM | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthsusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.